Please login to the form below
HTA
This page shows the latest HTA news and features for those working in and with pharma, biotech and healthcare.
NICE launches consultation on its methods of drug evaluation
diagnostics. The health technology assessment (HTA) agency launched a public consultation last week on a proposal for changes to the methods it uses to evaluate potential medical treatments. ... The HTA agency has already identified potential areas for
Latest news
-
Centre for Innovation in Regulatory Science awarded $1.09m Gates Foundation grant
health technology assessment (HTA) policies and processes.
-
NICE International relaunches, will offer advisory services
NICE has become one of the world’s most prominent and well-know health technology assessment (HTA) bodies since its inception in 1999. ... NICE International will build on the expertise of those within the organisation and draw on links with academic
-
NICE’s long-serving chief exec Sir Andrew Dillon to step down
NICE quickly became the world’s best-known and most prominent health technology assessment (HTA) body, and has set the standard for many other national institutes set up since then.
-
Who's calling the shots in European healthcare?
2019 has already been very eventful in terms of the debate about pharma’s future, including the question of how to proceed with plans for harmonisation of health technology assessment (HTA)
-
Europe urged to adapt faster to gene therapy challenges
Resistance to high prices, even with novel payment models. Europe’s leading nations should commit to a rapid overhaul of health technology assessment (HTA) and bold initiatives such as new ... Better-adapted health technology assessment (HTA) methods,
More from news
Approximately 32 fully matching, plus 150 partially matching documents found.
Latest Intelligence
-
Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
Establishing value, of course, necessitates assessment – whether that’s through a health technology assessment (HTA) style procedure or something else.
-
Great expectations: the urgent need for common purpose in Alzheimer’s disease
The access landscape is further complicated because many health technology assessment (HTA) methodologies are currently not geared up to evaluate these treatments. ... Yet NICE and many other HTA bodies limit their assessment to the cost-effectiveness of
-
Weirdos and misfits
This involves working with HTAs to evolve treatment assessment to be more meaningful for everyone and crucially to be more holistic and less siloed.
-
It started with a miss
Similarly, commercial teams need to drill down and understand HTA requirements within the disease category to ensure trials are designed to capture the necessary data for modelling. ... When drugs don’t receive HTA regulatory support in major markets,
-
Evolution or revolution: the latest review of NICE methods
preferences data could be used in HTA.
More from intelligence
Approximately 14 fully matching, plus 62 partially matching documents found.
Latest appointments
-
Open Access Consulting appoints new director
value dossiers, payer-focused objection handlers, stand-alone payer value propositions and local HTA submissions.
-
Claes Buxfeldt joins NDA
He becomes its new HTA director. AstraZeneca’s former global price and reimbursement director Claes Buxfeldt has joined the NDA advisory board. ... Buxfeldt’s new role at NDA will see him drive and develop the group’s service offerings in the HTA
-
Professor Carole Longson moves from NICE to the ABPI
She most recently spent the 18 years at the National Institute for Health and Care Excellence ( NICE), where she has led the HTA organisation’s technology appraisal programme.
-
VCLS appoints Carole Jones to senior market access role
her focus on expanding the company’s market access capabilities, spanning payer strategy, health economics and outcomes research (HEOR), health technology assessment (HTA) and communications support.
-
EFPIA's Richard Torbett to move to the ABPI
At the ABPI Torbett will focus on pricing, the Pharmaceutical Price Regulation Scheme (PPRS), health technology assessments (HTA) and value assessment, as well as market access in the UK.
More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.
Latest from PMHub
-
Let's be ambitious for patients and life sciences investment in Global Britain
But the UK also needs an HTA system fit for the future. ... From the Cancer Drugs Fund to the promised Innovation Drugs Fund, initiatives have been created as technical ‘work-arounds’ for NICE and for an HTA system that has not kept pace
-
Digital Therapeutics Landscape in Europe
OPEN Health introduce an overview of regulatory and HTA developments for digital therapeutics in Europe focusing on Germany and the UK.
-
Why are new medicinal products denied reimbursement in France?
Hence, similar to other markets, successful market access in France necessitates a thorough understanding of Health Technology Assessment (HTA) hurdles and the competitive landscape early in the product development, thorough market ... 9833. References.
-
The benefits of a expert-led market access strategy
Market access strategies have evolved over the years. Initially, the goal was to gain a positive recommendation from health technology assessment (HTA) submissions. ... The expectations from an expert-led market access strategy is no longer limited to
-
Speakers Announced: Maintaining Market Access Continuity through a Global Pandemic Webinar
This round table brings together leading experts from the pharmaceutical industry, HTA bodies and public health experts to discuss consequences, threats and opportunities, and how to maintain continuity. ... Ex-member of the Italian Government Drug
More from PMHub
Approximately 6 fully matching, plus 22 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Healthcare Senior Account Manager
-
Competitive
-
Medical Editor
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
-
Healthcare Account Director
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- New study identifies drugs that are safe to use in COVID-19 treatment
- Biogen advances Spinraza study in SMA patients treated with Novartis’ Zolgensma
- Inovio plans late-stage COVID-19 vaccine study in second quarter 2021
- CureVac set to begin phase 3 COVID-19 vaccine study in healthcare workers
- Experimental Chinese COVID-19 vaccine is safe, according to researchers
- UK pharmacies to begin administering COVID-19 vaccinations
- Live Webinar: COVID-19 Has Changed Live Events Forever!
- New hire and promotions announced at Evoke KYNE
- Amgen strikes $240m autoimmune deal with Evoq Therapeutics
- Lucid Group bolster its talent with a further twelve new starters for 2021
- UK pharmacies to begin administering COVID-19 vaccinations
- PHE study finds people who have had COVID-19 can still transmit the virus
PMHub
AMICULUM Limited
AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...
Latest intelligence
- AstraZeneca’s focus on diagnosing and managing chronic kidney disease
- People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
- Delphi Technique Virtual Co-creation: A Customer Story
- How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
- Three ways AI will change healthcare in the next decade
- Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...
Quick links
Infographics
